Mesoblast (MESO) Shares Outstanding (2014 - 2025)

Mesoblast (MESO) posted quarterly Shares Outstanding (Entity) of $129.0 for Q4 2025, up 13.16% year-on-year from $114.0 in Q4 2024, and down 100.0% on a QoQ basis from $120.8 million in Q2 2025.

Mesoblast (MESO) Shares Outstanding (2014 - 2025) Analysis & Trends

Mesoblast (MESO) has reported Shares Outstanding (Entity) for 11 consecutive years, with $129.0 the latest figure, recorded in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 13.16% year-over-year to $129.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129.0 (up 13.16% YoY) and the FY2025 annual result came in at $120.8 million, up 121999206.06% from the prior year.
  • Shares Outstanding (Entity) fell to $129.0 in Q4 2025 per MESO's latest filing, from $120.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for MESO reached as high as $120.8 million in Q2 2025 and fell as low as $60.0 in Q1 2021.
  • A 5-year average of $8.1 million and a median of $74.0 in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) slumped 32.94% — and 2025, when it jumped 121999206.06%.
  • Year by year, Shares Outstanding (Entity) stood at $65.0 in 2021, then gained by 13.85% to $74.0 in 2022, then jumped by 129.73% to $170.0 in 2023, then sank by 32.94% to $114.0 in 2024, then increased by 13.16% to $129.0 in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $129.0, $120.8 million, and $114.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Mesoblast 2.08 Bn 1.95 Bn - 1.29 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.29 Bn
Jun 30, 2025 1.21 Bn
Dec 31, 2024 1.14 Bn
Jun 30, 2024 986.70 Mn
Dec 31, 2023 851.46 Mn
Jun 30, 2023 369.52 Mn
Mar 31, 2023 368.29 Mn
Dec 31, 2022 368.29 Mn
Sep 30, 2022 348.04 Mn
Jun 30, 2022 324.45 Mn
Mar 31, 2022 324.78 Mn
Dec 31, 2021 324.05 Mn
Sep 30, 2021 324.02 Mn
Jun 30, 2021 302.53 Mn
Mar 31, 2021 302.22 Mn
Dec 31, 2020 293.18 Mn
Sep 30, 2020 291.24 Mn
Jun 30, 2020 264.41 Mn
Mar 31, 2020 268.83 Mn
Dec 31, 2019 267.21 Mn